Premenopausal antimüllerian hormone concentration is associated with subsequent atherosclerosis - Wikidata - awgldk - TriplyDB

Premenopausal antimüllerian hormone concentration is associated with subsequent atherosclerosis

Premenopausal antimüllerian hormone concentration is associated with subsequent atherosclerosis

http://www.wikidata.org/entity/Q36431307

about

Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications The type 2 anti-Müllerian hormone receptor has splice variants that are dominant-negative inhibitors Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females.Elderly men have low levels of anti-Müllerian hormone and inhibin B, but with high interpersonal variation: a cross-sectional study of the sertoli cell hormones in 615 community-dwelling men.The Daily Profiles of Circulating AMH and INSL3 in Men are Distinct from the Other Testicular Hormones, Inhibin B and Testosterone.Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV Relative levels of the proprotein and cleavage-activated form of circulating human anti-Müllerian hormone are sexually dimorphic and variable during the life cycle.Early Vascular Damage in Young Women with DM-1 and Its Relation to Anti-Müllerian Hormone: A Cross-Sectional Study The association of low ovarian reserve with cardiovascular disease risk: a cross-sectional population-based study.Serum variations of anti-mullerian hormone and total testosterone with aging in healthy adult Iranian men: A population-based study.Anti-Müllerian hormone - is it a clinically useful test?Serum anti-mullerian hormone and all-cause mortality in men.Circulating anti-Müllerian hormone (AMH) associates with the maturity of boys' drawings: Does AMH slow cognitive development in males?Association between vascular health and ovarian ageing in type 1 diabetes mellitus.Low antimullerian hormone levels may be associated with cardiovascular risk markers in women with diminished ovarian reserve.Anti-Müllerian Hormone Levels in Preeclampsia: A Systematic Review of the Literature

P2860

Q28239980-C9C935CF-8E03-4357-A45D-5CB8B67AF570 Q28511212-8A707C46-F583-497E-8056-839D3960CCFA Q33682425-261362BE-15E6-4A10-8D0D-EA8D25649835 Q34769332-778B2A60-09CE-424C-AD2D-EA48D087CE60 Q34936466-AC29DB81-1982-454E-90CE-7E8F850710F5 Q35698885-4335A1F4-FA88-43C8-830D-9803878ABAF2 Q36463715-A888D74A-740A-4BE0-B886-61DE28B8092B Q36918737-3D44BD97-AF0A-45CF-8848-734822765482 Q37250035-5B37F542-363B-4AF0-BED6-CD86ACEEECF4 Q38833903-4116D086-6A45-4F21-9054-57C3089F13DD Q40120045-C943EC03-71A0-493E-B56E-5ADBA94B4EB1 Q43755331-141CF084-FB74-40F9-ABF6-A9A5987FD6DE Q48293859-553EBC79-42D3-4D5A-8436-528CE29A32D5 Q48309003-8FA822F1-001D-48D7-8969-509D612FE08B Q53128176-45C0AC22-0639-42CD-9553-B4EB2FC9FB79 Q53807393-8DB77845-2D5C-47AE-AEDD-44AEB07B2FD9 Q57151278-DB27EFB3-B651-4CA9-A921-47D7C1BFA057

P2860

Premenopausal antimüllerian hormone concentration is associated with subsequent atherosclerosis

http://www.wikidata.org/entity/Q36431307

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Premenopausal antimüllerian ho ...... ith subsequent atherosclerosis

@ast

Premenopausal antimüllerian ho ...... ith subsequent atherosclerosis

@en

type

label

Premenopausal antimüllerian ho ...... ith subsequent atherosclerosis

@ast

Premenopausal antimüllerian ho ...... ith subsequent atherosclerosis

@en

prefLabel

Premenopausal antimüllerian ho ...... ith subsequent atherosclerosis

@ast

Premenopausal antimüllerian ho ...... ith subsequent atherosclerosis

@en

P1433

Q36431307-89CD4080-B1B8-4C12-BF81-FB3A0F10A396

P1476

Q36431307-62C6049A-0BFF-4359-9C87-DD7F8B95C2F1

P2093

Q36431307-07D60681-9AC9-4351-BB48-AB030B5E245B

Q36431307-D3D8F16A-BF83-4073-881F-DB37AD7F56FD

Q36431307-DEF3FE07-6C18-4A8A-AEF8-660FDD792CFF

Q36431307-F1139247-4E8C-49F2-AEF7-A2D85B58DD86

P2860

Q36431307-039C6802-6592-47C7-9B9B-7678A3F6D1C0

Q36431307-04789943-AD7A-4730-94FF-DD76814B3AA9

Q36431307-093A2F76-78DD-4D16-A0AD-2F2C1FC6DD0E

Q36431307-0E34E645-6370-4E74-97BE-B8AB8BFD3D7C

Q36431307-0F729D6E-4260-4CAD-B53B-F2FF6F69B80C

Q36431307-10FFF016-2884-4494-A184-A79895BE2F4A

Q36431307-1AF843B9-B04F-4E41-90F0-5C94C13E863C

Q36431307-1FF11531-9CFF-47A4-BC2F-AB65CBAA305E

Q36431307-292A1EBA-E243-48E5-BDB1-501C178378DF

Q36431307-299D5CFB-71BF-4118-9926-BEAE3E2DF86F

P304

Q36431307-ADDAA08F-931A-4B31-893E-A8E257F7CBDB

P31

Q36431307-DD641923-7070-4DD6-9100-C8E564B2E98F

P356

Q36431307-E2A1E43B-5010-40DD-9F5F-1E42BD223F9F

P407

Q36431307-A70131AC-7FCE-4B59-A8BA-7C1A04DFFE26

P433

Q36431307-47ECC809-C3BF-45F5-BD3A-82FB10BFE212

P478

Q36431307-F0EF711B-EC2D-4B90-B313-7D854BA2C10E

P577

Q36431307-0A3CE1C8-EBDE-4286-9BF2-477A44CC680A

P698

Q36431307-E9FEB5EC-8906-4A07-A2BF-89D8F6195036

P921

Q36431307-5E9977C0-AECD-43DD-A20C-D5A8923E2C8B

P932

Q36431307-4B349A3F-D639-4049-BC88-210525A4DD74

P356

GME.0B013E31825B4FE2

P1433

P1476

Premenopausal antimüllerian ho ...... ith subsequent atherosclerosis

@en

P2093

Haiying Chen

http://www.w3.org/2001/XMLSchema#string

Jay R Kaplan

http://www.w3.org/2001/XMLSchema#string

Susan E Appt

http://www.w3.org/2001/XMLSchema#string

Thomas B Clarkson

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association

Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques.

Experimental induction of reduced ovarian reserve in a nonhuman primate model (Macaca fascicularis)

Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens.

Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.

Impairment of ovarian function and associated health-related abnormalities are attributable to low social status in premenopausal monkeys and not mitigated by a high-isoflavone soy diet.

A "window of opportunity:" the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent.

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease.

The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age.

Endocrine profile of an ovariectomized cynomolgus monkey (Macaca fascicularis) with a supernumerary ovary.

P304

1353-1359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/GME.0B013E31825B4FE2

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22929037

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3509243

http://www.w3.org/2001/XMLSchema#string